Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2022-04-14 4:42 pm Purchase | 13G | VISTAGEN THERAPEUTICS, INC. CO VTGN | COMMODORE CAPITAL LP | 10,455,910 5.1% | 10,455,910 (New Position) | View |
| 2022-02-15 2:51 pm Sale | 13G | VISTAGEN THERAPEUTICS, INC. CO VTGN | ACUTA CAPITAL PARTNERS LLC | 11,736,283 5.9% | -728,691 (-5.85%) | View |
| 2022-02-14 4:20 pm Purchase | 13G | VISTAGEN THERAPEUTICS, INC. CO VTGN | Venrock Healthcare Capital Partners II L.P. | 16,047,286 8% | 1,807,049 (+12.69%) | View |
| 2022-02-11 4:58 pm Purchase | 13G | VISTAGEN THERAPEUTICS, INC. CO VTGN | ORBIMED ADVISORS LLC | 10,519,240 5.3% | 740,440 (+7.57%) | View |
| 2022-02-04 4:12 pm Purchase | 13G | VISTAGEN THERAPEUTICS, INC. CO VTGN | BlackRock Inc. BLK | 11,894,193 6% | 11,894,193 (New Position) | View |
| 2022-02-04 10:54 am Purchase | 13G | VISTAGEN THERAPEUTICS, INC. CO VTGN | FRANKLIN RESOURCES INC BEN | 10,117,999 5.1% | 10,117,999 (New Position) | View |
| 2021-04-29 10:17 am Purchase | 13D | VISTAGEN THERAPEUTICS, INC. CO VTGN | Growth Equity Opportunities 17 LLC | 16,302,596 8.6% | 6,942,596 (+74.17%) | View |
| 2021-03-22 06:06 am Purchase | 13G | VISTAGEN THERAPEUTICS, INC. CO VTGN | ACUTA CAPITAL PARTNERS LLC | 12,464,974 8.4% | 4,964,974 (+66.20%) | View |
| 2021-02-16 4:11 pm Purchase | 13G | VISTAGEN THERAPEUTICS, INC. CO VTGN | Venrock Healthcare Capital Partners II L.P. | 14,240,237 9.99% | 14,240,237 (New Position) | View |
| 2021-02-16 06:14 am Purchase | 13G | VISTAGEN THERAPEUTICS, INC. CO VTGN | ACUTA CAPITAL PARTNERS LLC | 7,500,000 5.4% | 7,500,000 (New Position) | View |
| 2021-02-12 5:12 pm Purchase | 13G | VISTAGEN THERAPEUTICS, INC. CO VTGN | ORBIMED ADVISORS LLC | 9,778,800 6.9% | 9,778,800 (New Position) | View |
| 2021-01-22 5:26 pm Purchase | 13G | VISTAGEN THERAPEUTICS, INC. CO VTGN | Rosalind Advisors Inc. | 5,377,113 4.8% | 1,377,113 (+34.43%) | View |
| 2021-01-04 06:00 am Purchase | 13D | VISTAGEN THERAPEUTICS, INC. CO VTGN | Growth Equity Opportunities 17 LLC | 9,360,000 6.8% | 9,360,000 (New Position) | View |
| 2020-09-18 4:56 pm Purchase | 13G | VISTAGEN THERAPEUTICS, INC. CO VTGN | Rosalind Advisors Inc. | 4,000,000 5.4% | 4,000,000 (New Position) | View |
| 2020-02-11 12:12 pm Sale | 13G | VISTAGEN THERAPEUTICS, INC. CO VTGN | SPHERA FUNDS MANAGEMENT LTD. | 1,314,949 2.67% | -1,473,918 (-52.85%) | View |
| 2020-01-29 06:02 am Purchase | 13G | VISTAGEN THERAPEUTICS, INC. CO VTGN | Lincoln Park Capital Fund LLC | 4,614,602 9.62% | 4,614,602 (New Position) | View |